LifeTech Scientific Corp
HKEX:1302
LifeTech Scientific Corp
HKEX:1302
Price:
1.95
HKD
2.63%
Market Cap:
HK$9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
LifeTech Scientific Corp
HKEX:1302
|
CN |
|
Kye-Ryong Construction Industrial Co Ltd
KRX:013580
|
KR |
|
SFL Corporation Ltd
NYSE:SFL
|
BM |
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
MY |
|
UBS Group AG
SIX:UBSG
|
CH |
|
G
|
Gdex Bhd
KLSE:GDEX
|
MY |
|
Singularity Future Technology Ltd
NASDAQ:SGLY
|
US |
Cash Flow Statement
Cash Flow Statement
LifeTech Scientific Corp
LifeTech Scientific Corp
Currency: CNY
| Jun-2013 | Dec-2013 | Dec-2017 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
0
|
(53)
|
194
|
167
|
0
|
171
|
0
|
243
|
0
|
333
|
0
|
378
|
0
|
176
|
0
|
199
|
0
|
|
| Depreciation & Amortization |
0
|
7
|
15
|
28
|
0
|
50
|
0
|
57
|
0
|
56
|
0
|
60
|
0
|
69
|
0
|
79
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
132
|
0
|
155
|
0
|
22
|
0
|
65
|
0
|
249
|
61
|
194
|
194
|
|
| Other Non-Cash Items |
0
|
94
|
10
|
55
|
0
|
119
|
0
|
16
|
0
|
(4)
|
0
|
86
|
0
|
272
|
0
|
146
|
0
|
|
| Cash Taxes Paid |
0
|
13
|
51
|
40
|
0
|
47
|
0
|
44
|
40
|
60
|
56
|
71
|
64
|
80
|
93
|
78
|
54
|
|
| Cash Interest Paid |
0
|
1
|
6
|
0
|
1
|
19
|
21
|
26
|
26
|
3
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
|
| Change in Working Capital |
(20)
|
(13)
|
(63)
|
(68)
|
296
|
(64)
|
268
|
23
|
432
|
56
|
486
|
(136)
|
367
|
(98)
|
298
|
(103)
|
610
|
|
| Cash from Operating Activities |
36
N/A
|
35
-3%
|
155
+343%
|
182
+18%
|
296
+62%
|
275
-7%
|
268
-3%
|
339
+26%
|
432
+28%
|
441
+2%
|
486
+10%
|
388
-20%
|
367
-5%
|
418
+14%
|
298
-29%
|
321
+8%
|
610
+90%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(47)
|
(52)
|
(112)
|
(64)
|
(96)
|
(102)
|
(112)
|
(105)
|
(179)
|
(276)
|
(280)
|
(226)
|
(211)
|
(206)
|
(283)
|
(205)
|
(45)
|
|
| Other Items |
(7)
|
(74)
|
(37)
|
(243)
|
(338)
|
(154)
|
(146)
|
(237)
|
(502)
|
237
|
427
|
(232)
|
(235)
|
(248)
|
(126)
|
(312)
|
(521)
|
|
| Cash from Investing Activities |
(54)
N/A
|
(126)
-136%
|
(149)
-18%
|
(308)
-107%
|
(434)
-41%
|
(256)
+41%
|
(258)
-1%
|
(342)
-33%
|
(681)
-99%
|
(39)
+94%
|
147
N/A
|
(458)
N/A
|
(446)
+3%
|
(454)
-2%
|
(409)
+10%
|
(518)
-26%
|
(566)
-9%
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
8
|
2
|
(346)
|
(350)
|
6
|
816
|
809
|
(153)
|
(309)
|
(203)
|
(54)
|
(21)
|
(161)
|
(146)
|
2
|
|
| Net Issuance of Debt |
154
|
119
|
(200)
|
24
|
306
|
288
|
47
|
(131)
|
(291)
|
(118)
|
(6)
|
(12)
|
(10)
|
193
|
291
|
(7)
|
(104)
|
|
| Other |
(0)
|
(1)
|
(6)
|
(0)
|
(1)
|
(10)
|
(12)
|
(10)
|
(6)
|
15
|
9
|
0
|
3
|
11
|
38
|
36
|
9
|
|
| Cash from Financing Activities |
154
N/A
|
118
-23%
|
(199)
N/A
|
26
N/A
|
(41)
N/A
|
(73)
-78%
|
41
N/A
|
675
+1 554%
|
512
-24%
|
(256)
N/A
|
(306)
-19%
|
(215)
+30%
|
(61)
+72%
|
183
N/A
|
168
-8%
|
(117)
N/A
|
(93)
+21%
|
|
| Change in Cash | ||||||||||||||||||
| Effect of Foreign Exchange Rates |
1
|
1
|
(1)
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
(0)
|
(3)
|
(1)
|
1
|
(1)
|
(1)
|
|
| Net Change in Cash |
137
N/A
|
27
-80%
|
(193)
N/A
|
(99)
+49%
|
(178)
-80%
|
(54)
+70%
|
51
N/A
|
673
+1 217%
|
264
-61%
|
148
-44%
|
329
+123%
|
(285)
N/A
|
(142)
+50%
|
146
N/A
|
57
-61%
|
(314)
N/A
|
(50)
+84%
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(11)
N/A
|
(17)
-63%
|
43
N/A
|
118
+172%
|
200
+70%
|
173
-13%
|
156
-10%
|
233
+50%
|
252
+8%
|
165
-34%
|
206
+25%
|
162
-21%
|
156
-3%
|
213
+36%
|
14
-93%
|
116
+708%
|
565
+386%
|
|
Switch to:
Switch to:
See Also
Discover More
